Stock listing

NASDAQ:ADRX ADARx Pharmaceuticals, Inc. Stock

Home listing (NASDAQ) of ADARx Pharmaceuticals, Inc.

Follow ADARx Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:ADRX

$17.00 USD -0.85 (-4.8%)

Close on Oct 30, 2026

Past month -12.1% · daily closes, Sep 25, 2026 – Oct 30, 2026, adjusted for splits
Day range
$16.30 – $18.10 USDOct 30, 2026
Volume
542,258 sharesOct 30, 2026
Market cap
$1.88B USDAt the close on Oct 30, 2026 · price × 110.7M shares outstanding
Traded on an average day
$13.20M USDMedian day 430,850 shares · last 3 months, Sep 25, 2026 – Oct 30, 2026
ADARx Pharmaceuticals, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ADRX · Home$17.00 USD-0.85 (-4.8%)542,258$18.10$18.10$16.30$17.85Close on Oct 30, 2026

Daily closes

Last 3 months, Sep 25, 2026 – Oct 30, 2026 · NASDAQ:ADRX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$17.00-0.85-4.8%$18.10$18.10$16.30542,258
$17.85-0.10-0.6%$18.00$18.75$17.65402,000
$17.95-0.18-1.0%$18.22$18.36$17.66264,700
$18.13+0.32+1.8%$17.99$18.80$17.71293,600
$17.81+0.18+1.0%$17.77$19.07$17.5099,600
$17.63-0.05-0.3%$17.68$18.33$17.00177,600
$17.68+0.55+3.2%$17.18$17.88$17.18181,500
$17.13-0.55-3.1%$17.58$18.17$17.00441,500
$17.68+0.05+0.3%$17.98$18.55$16.611,074,900
$17.63-0.02-0.1%$17.76$18.33$17.05262,000
$17.65-0.05-0.3%$17.73$18.60$17.50247,100
$17.70-0.13-0.7%$17.75$18.33$17.50283,400
$17.83+0.13+0.7%$17.72$18.28$17.31285,500
$17.70-0.27-1.5%$18.00$18.82$17.57221,000
$17.97+0.19+1.1%$17.78$18.75$17.57350,800
$17.78+0.10+0.6%$17.70$18.19$17.06688,500
$17.68+0.35+2.0%$17.13$18.10$16.64420,200
$17.33-1.25-6.7%$18.33$18.70$17.20705,600
$18.58-0.47-2.5%$19.05$19.57$18.011,034,900
$19.05+0.80+4.4%$18.25$19.40$17.30913,900
$18.25-1.29-6.6%$19.31$19.53$17.85937,000
$19.54-0.40-2.0%$19.99$20.77$18.99962,200
$19.94-0.70-3.4%$20.65$21.61$19.23788,800
$20.64+0.55+2.7%$19.90$21.50$19.511,299,400
$20.09+0.74+3.8%$19.00$21.77$18.501,205,200
$19.35——$22.10$23.21$19.004,213,100
Ticker
NASDAQ:ADRX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering

Oct 1, 2026

Closed $18.25 (-6.6%) on Oct 2, 2026

ADARx Pharmaceuticals surges following upsized IPO

Sep 25, 2026

Closed $20.09 (+3.8%) on Sep 28, 2026

All ADARx Pharmaceuticals, Inc. news

Financings

  • Public offering of common stock

    Oct 1, 2026

    Closed: US$17 a share · J.P. Morgan +4

    Dealers: J.P. Morgan (co-lead), Morgan Stanley (co-lead), TD Cowen (co-lead), UBS Investment Bank (co-lead), LifeSci Capital

    Closed Oct 1, 2026

  • Private placement of common stock

    Oct 1, 2026

    Closed: US$17 a share

    Buyers: AbbVie (5,255,542 shares of common stock at $17.00 per share)

    Closed Oct 1, 2026

Read by 6ix AI from the company's releases

Decks

ADARx Pharmaceuticals, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 2 in all · newest Oct 1, 2026 · oldest 2026
Decks
1 deck · latest September 2026

Where ADARx Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ADRX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:ADRXBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about ADARx Pharmaceuticals, Inc.